Assessing acceptability of the fourth dose against COVID-19 among Chinese adults: A population-based survey

References

• (JHU) CfSSaECaJHU. COVID-19 dashboard 2023. Updated 2023 Feb 5. [accessed 2023 Feb 5]. https://coronavirus.jhu.edu/map.html.
   Google Scholar
• Rana R, Kant R, Huirem RS, Bohra D, Ganguly NK. Omicron variant: current insights and future directions. Microbiol Res. 2022;265:127204. [accessed 2022 Sept 25]. doi:10.1016/j.micres.2022.127204.
   PubMedGoogle Scholar
• Orgnization WH. Tracking SARS-CoV-2 variants 2022. Updated 2022 Nov 23. [accessed 2022 Nov 23]. https://www.who.int/activities/tracking-SARS-CoV-2-variants/.
   Google Scholar
• Sun Y, Dai H, Wang P, Zhang X, Cui D, Huang Y, Zhang J, Xiang T. Will people accept a third booster dose of the COVID-19 vaccine? A cross-sectional study in China. Front Public Health. 2022;10:914950. [accessed 2022 July 30]. doi:10.3389/fpubh.2022.914950.
   PubMed Web of Science ®Google Scholar
• Yu B, Chang J. The first Chinese oral anti-COVID-19 drug Azvudine launched. Innovation. 2022;3(6):100321. [accessed 2022 Sept 16]. doi:10.1016/j.xinn.2022.100321.
   Google Scholar
• Joshi S, Parkar J, Ansari A, Vora A, Talwar D, Tiwaskar M, Patil S, Barkate H. Role of favipiravir in the treatment of COVID-19. Int J Infect Dis. 2021;102:501–10. [accessed 2020 Nov 2]. doi:10.1016/j.ijid.2020.10.069.
   PubMed Web of Science ®Google Scholar
• Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Amir O, Freedman L, Alroy-Preis S, Ash N, Huppert A, Milo R. Protection by a fourth dose of BNT162b2 against Omicron in Israel. N Engl J Med. 2022;386(18):1712–20. [accessed 2022 Apr 6]. doi:10.1056/NEJMoa2201570.
   PubMed Web of Science ®Google Scholar
• Galanis P, Vraka I, Katsiroumpa A, Siskou O, Konstantakopoulou O, Katsoulas T, Mariolis‐sapsakos T, Kaitelidou D. Predictors of second COVID-19 booster dose or new COVID-19 vaccine hesitancy among nurses: a cross-sectional study. J Clin Nurs. 2022. [accessed 2022 Nov 9]. doi:10.1111/jocn.16576.
   Web of Science ®Google Scholar
• Tanne JH. Covid-19: Pfizer asks US regulator to authorise fourth vaccine dose for over 65s. Bmj. 2022;376:o711. [accessed 2022 Mar 19]. doi:10.1136/bmj.o711.
   PubMedGoogle Scholar
• (IVAC) IVAC. COVID-19 Data 2022. Updated 2022 Nov 24. [accessed 2022 Nov24]. https://view-hub.org/covid-19/effectiveness-studies?targetboost=boost2&field_covid_studies_variant_tabl=23732&field_covid_studies_population=23423&field_covid_studies_vaccine_all=23615.
   Google Scholar
• Orgnization WH. Weekly epidemiological update on COVID-19- 26 October 2022. Updated 2022 Oct 26. [accessed 2022 Nov23]. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—26-october-2022.
   Google Scholar
• Grewal R, Kitchen SA, Nguyen L, Buchan SA, Wilson SE, Costa AP, Kwong JC. Effectiveness of a fourth dose of COVID-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study. Bmj. 2022;378:e071502. [accessed 2022 July 7]. doi:10.1136/bmj-2022-071502.
   PubMedGoogle Scholar
• Magen O, Waxman JG, Makov-Assif M, Vered R, Dicker D, Hernán MA, Lipsitch M, Reis BY, Balicer RD, Dagan N. Fourth dose of BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2022;386(17):1603–14. [accessed 2022 Apr 14]. doi:10.1056/NEJMoa2201688.
   PubMed Web of Science ®Google Scholar
• Rodewald L, Wu D, Yin Z, Feng Z. Vaccinate with confidence and finish Strong. China CDC Wkly. 2022;4(37):828–31. [accessed 2022 Oct 27]. doi:10.46234/ccdcw2022.172.
   PubMedGoogle Scholar
• Press conference of the state council joint prevention and control mechanism 2022. Updated 2022 Nov 5. [accessed 2022 Nov 23]. http://www.gov.cn/xinwen/gwylflkjz212/index.htm.
   Google Scholar
• Zhong J, Liu S, Cui T, Li J, Zhu F, Zhong N, Huang W, Zhao Z, Wang Z. Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants. Emerg Microbes Infect. 2022;11(1):2689–97. [accessed 2022 Oct 6]. doi:10.1080/22221751.2022.2132881.
   PubMed Web of Science ®Google Scholar
• Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, et al. Homologous and heterologous Covid-19 booster vaccinations. N Engl J Med. 2022;386(11):1046–57. [accessed 2022 Jan 27]. doi:10.1056/NEJMoa2116414.
   PubMed Web of Science ®Google Scholar
• Deng J, Ma Y, Liu Q, Du M, Liu M, Liu J. Comparison of the effectiveness and safety of heterologous booster doses with homologous booster doses for SARS-CoV-2 vaccines: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(17):10752. [accessed 2022 Sept 10]. doi:10.3390/ijerph191710752.
   PubMed Web of Science ®Google Scholar
• Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175–83. [accessed 1988 Jan 1]. doi:10.1177/109019818801500203.
   PubMedGoogle Scholar
• Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11(1):1–47. [accessed 1984 Jan 1]. doi:10.1177/109019818401100101.
   PubMedGoogle Scholar
• Cummings KM, Jette AM, Rosenstock IM. Construct validation of the health belief model. Health Educ Monogr. 1978;6(4):394–405. [accessed 1978 Jan 1]. doi:10.1177/109019817800600406.
   PubMedGoogle Scholar
• Qin C, Wang R, Tao L, Liu M, Liu J. Acceptance of a third dose of COVID-19 vaccine and associated factors in China based on health belief model: a national cross-sectional study. Vaccines. 2022;10(1). [accessed 2022 Jan 23]. doi:10.3389/fpubh.2022.986916.
   Web of Science ®Google Scholar
• Hossain MB, Alam MZ, Islam MS, Sultan S, Faysal MM, Rima S, Hossain MA, Mamun AA. COVID-19 vaccine hesitancy among the adult population in Bangladesh: a nationwide cross-sectional survey. PLoS One. 2021;16(12):e0260821. [accessed 2021 Dec 10]. doi:10.1371/journal.pone.0260821.
   PubMed Web of Science ®Google Scholar
• Qin C, Wang R, Tao L, Liu M, Liu J. Association between risk perception and acceptance for a booster dose of COVID-19 vaccine to children among child caregivers in China. Front Public Health. 2022;10:834572. [accessed 2022 Apr 5]. doi:10.3389/fpubh.2022.834572.
   PubMed Web of Science ®Google Scholar
• Chen H, Li X, Gao J, Liu X, Mao Y, Wang R, Zheng P, Xiao Q, Jia Y, Fu H, et al. Health belief model perspective on the control of COVID-19 vaccine hesitancy and the promotion of vaccination in China: web-based cross-sectional study. J Med Internet Res. 2021;23(9):e29329. [accessed 2021 July 20]. doi:10.2196/29329.
   PubMed Web of Science ®Google Scholar
• Hossain MB, Alam MZ, Islam MS, Sultan S, Faysal MM, Rima S, Hossain MA, Mamun AA. Health belief model, theory of planned behavior, or psychological antecedents: what predicts COVID-19 vaccine hesitancy better among the Bangladeshi adults? Front Public Health. 2021;9:711066. [accessed 2021 Sept 8]. doi:10.3389/fpubh.2021.711066.
   PubMed Web of Science ®Google Scholar
• Suess C, Maddock J, Dogru T, Mody M, Lee S. Using the health belief model to examine travelers’ willingness to vaccinate and support for vaccination requirements prior to travel. Tour Manag. 2022;88:104405. [accessed 2021 Aug 31]. doi:10.1016/j.tourman.2021.104405.
   PubMed Web of Science ®Google Scholar
• Tao L, Wang R, Han N, Liu J, Yuan C, Deng L, Han C, Sun F, Liu M, Liu J. Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model. Hum Vaccin Immunother. 2021;17(8):2378–88. [accessed 2021 May 15]. doi:10.1080/21645515.2021.1892432.
   PubMed Web of Science ®Google Scholar
• Vermandere H, van Stam MA, Naanyu V, Michielsen K, Degomme O, Oort F. Uptake of the human papillomavirus vaccine in Kenya: testing the health belief model through pathway modeling on cohort data. Global Health. 2016;12(1):72. [accessed 2016 Nov 17]. doi:10.1186/s12992-016-0211-7.
   PubMedGoogle Scholar
• Zambri F, Perilli I, Quattrini A, Marchetti F, Colaceci S, Giusti A. Health belief Model efficacy in explaining and predicting intention or uptake pertussis vaccination during pregnancy. Ann Ist Super Sanita. 2021;57(2):167–73. [accessed 2021 June 17]. doi:10.4415/ann_21_02_09.
   PubMed Web of Science ®Google Scholar
• Bureau SS. Bulletin of the seventh national census 2021. [ Updated 2021 May 11. [accessed 2022 Nov24]. http://www.gov.cn/guoqing/2021-05/13/content_5606149.htm.
   Google Scholar
• Abdelmoneim SA, Sallam M, Hafez DM, Elrewany E, Mousli HM, Hammad EM, Elkhadry SW, Adam MF, Ghobashy AA, Naguib M, et al. COVID-19 vaccine booster dose acceptance: systematic review and meta-analysis. Trop Med Infect Dis. 2022;7(10):298. [accessed 2022 Oct 27]. doi:10.3390/tropicalmed7100298.
   PubMedGoogle Scholar
• Yadete T, Batra K, Netski DM, Antonio S, Patros MJ, Bester JC. Assessing acceptability of COVID-19 vaccine booster dose among adult Americans: a cross-sectional study. Vaccines. 2021;9(12):1424. [accessed 2021 Dec 29]. doi:10.3390/vaccines9121424.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Kobashi Y, Kawamura T, Shimazu Y, Nishikawa Y, Omata F, Zhao T, Yamamoto C, Kaneko Y, Nakayama A, et al. Factors associated with COVID-19 vaccine booster hesitancy: a retrospective cohort study, Fukushima vaccination community survey. Vaccines. 2022;10(4). [accessed 2022 Apr 24]. doi:10.3390/vaccines10040515.
   Web of Science ®Google Scholar
• Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2). [accessed 2021 Mar 7]. doi:10.3390/vaccines9020160.
   Web of Science ®Google Scholar
• Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35(4):325–30. [accessed 2020 Apr 23]. doi:10.1007/s10654-020-00634-3.
   PubMed Web of Science ®Google Scholar
• Palamenghi L, Barello S, Boccia S, Graffigna G. Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy. Eur J Epidemiol. 2020;35(8):785–88. [accessed 2020 Aug 19]. doi:10.1007/s10654-020-00675-8.
   PubMed Web of Science ®Google Scholar
• Wang R, Tao L, Han N, Liu J, Yuan C, Deng L, Han C, Sun F, Chi L, Liu M, et al. Acceptance of seasonal influenza vaccination and associated factors among pregnant women in the context of COVID-19 pandemic in China: a multi-center cross-sectional study based on health belief model. BMC Pregnancy Childbirth. 2021;21(1):745. [accessed 2021 Nov 5]. doi:10.1186/s12884-021-04224-3.
   PubMed Web of Science ®Google Scholar
• Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961. [accessed 2020 Dec 18]. doi:10.1371/journal.pntd.0008961.
   PubMed Web of Science ®Google Scholar
• Baccolini V, Renzi E, Isonne C, Migliara G, Massimi A, De Vito C, Marzuillo C, Villari P. COVID-19 vaccine hesitancy among Italian university students: a cross-sectional survey during the first months of the vaccination campaign. Vaccines. 2021;9(11):1292. [accessed 2021 Nov 28]. doi:10.3390/vaccines9111292.
   PubMed Web of Science ®Google Scholar
• Bartoš V, Bauer M, Cahlíková J, Chytilová J. Communicating doctors’ consensus persistently increases COVID-19 vaccinations. Nature. 2022;606(7914):542–49. [accessed 2022 June 2]. doi:10.1038/s41586-022-04805-y.
   PubMed Web of Science ®Google Scholar
• Du M, Tao L, Liu J. The association between risk perception and COVID-19 vaccine hesitancy for children among reproductive women in China: an online survey. Front Med. 2021;8:741298. [accessed 2021 Sept 28]. doi:10.3389/fmed.2021.741298.
   Web of Science ®Google Scholar
• Kelly BJ, Southwell BG, McCormack LA, Bann CM, MacDonald PDM, Frasier AM, Bevc CA, Brewer NT, Squiers LB. Predictors of willingness to get a COVID-19 vaccine in the U.S. BMC Infect Dis. 2021;21(1):338. [accessed 2021 Apr 14]. doi:10.1186/s12879-021-06023-9.
   PubMed Web of Science ®Google Scholar
• Orji R, Vassileva J, Mandryk R. Towards an effective health interventions design: an extension of the health belief model. Online J Public Health Inform. 2012;4(3). [accessed 2012 Jan 1]. doi:10.5210/ojphi.v4i3.4321.
   PubMedGoogle Scholar
• Shahnazi H, Ahmadi-Livani M, Pahlavanzadeh B, Rajabi A, Hamrah MS, Charkazi A. Assessing preventive health behaviors from COVID-19: a cross sectional study with health belief model in Golestan Province, Northern of Iran. Infect Dis Poverty. 2020;9(1):157. [accessed 2020 Nov 19]. doi:10.1186/s40249-020-00776-2.
   PubMed Web of Science ®Google Scholar
• Jadil Y, Ouzir M. Exploring the predictors of health-protective behavior during the COVID-19 pandemic: a multi-country comparison. Environ Res. 2021;199:111376. [accessed 2021 May 28]. doi:10.1016/j.envres.2021.111376.
   PubMed Web of Science ®Google Scholar
• Costa Clemens SA, Weckx L, Clemens R, Almeida Mendes AV, Ramos Souza A, Silveira MBV, da Guarda SNF, de Nobrega MM, de Moraes Pinto MI, Gonzalez IGS, et al. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Lancet. 2022;399(10324):521–29. [accessed 2022 Jan 26]. doi:10.1016/s0140-6736(22)00094-0.
   PubMed Web of Science ®Google Scholar
• Andrejko KL, Pry J, Myers JF, Jewell NP, Openshaw J, Watt J, Jain S, Lewnard JA, Samani H, Li SS, et al. Prevention of Coronavirus disease 2019 (COVID-19) by mRNA-Based vaccines within the general population of California. Clin Infect Dis. 2022;74(8):1382–89. [accessed 2021 July 21]. doi:10.1093/cid/ciab640.
   PubMed Web of Science ®Google Scholar
• Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 vaccination hesitancy in the United States: a rapid national assessment. J Community Health. 2021;46(2):270–77. [accessed 2021 Jan 4]. doi:10.1007/s10900-020-00958-x.
   PubMed Web of Science ®Google Scholar
• Quinn SC, Jamison AM, Freimuth V. Communicating effectively about emergency use authorization and vaccines in the COVID-19 pandemic. Am J Public Health. 2021;111(3):355–58. [accessed 2020 Nov 26]. doi:10.2105/ajph.2020.306036.
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–28. [accessed 2020 Oct 22]. doi:10.1038/s41591-020-1124-9.
   PubMed Web of Science ®Google Scholar
• Faasse K, Newby J. Public perceptions of COVID-19 in Australia: perceived risk, knowledge, health-protective behaviors, and vaccine intentions. Front Psychol. 2020;11:551004. [accessed 2020 Oct 30]. doi:10.3389/fpsyg.2020.551004.
   PubMed Web of Science ®Google Scholar
• Wang R, Qin C, Du M, Liu Q, Tao L, Liu J. The association between social media use and hesitancy toward COVID-19 vaccine booster shots in China: a web-based cross-sectional survey. Hum Vaccin Immunother. 2022;18(5):2065167. [accessed 2022 June 8]. doi:10.1080/21645515.2022.2065167.
   PubMed Web of Science ®Google Scholar
• Limaye RJ, Holroyd TA, Blunt M, Jamison AF, Sauer M, Weeks R, Wahl B, Christenson K, Smith C, Minchin J, et al. Social media strategies to affect vaccine acceptance: a systematic literature review. Expert Rev Vaccines. 2021;20(8):959–73. [accessed 2021 July 2]. doi:10.1080/14760584.2021.1949292.
   PubMed Web of Science ®Google Scholar
• Daley MF, Glanz JM. Using social media to increase vaccine acceptance. Acad Pediatr. 2021;21(4, Supplement):S32–33. doi:10.1016/j.acap.2020.10.018.
   PubMed Web of Science ®Google Scholar
• Qin C, Liu Q, Du M, Yan W, Tao L, Wang Y, Liu M, Liu J. Neighborhood social cohesion is associated with the willingness toward the booster dose of COVID-19 vaccines among the Chinese older population. Hum Vaccin Immunother. 2022;18(6):2140530. [accessed 2022 Nov 15]. doi:10.1080/21645515.2022.2140530.
   PubMed Web of Science ®Google Scholar
• Tan CY, Chiew CJ, Lee VJ, Ong B, Lye DC, Tan KB. Effectiveness of a fourth Dose of COVID-19 mRNA vaccine against Omicron variant among elderly people in Singapore. Ann Intern Med. 2022;175(11):1622–23. [accessed 2022 Sept 13]. doi:10.7326/m22-2042.
   PubMed Web of Science ®Google Scholar
• Gazit S, Saciuk Y, Perez G, Peretz A, Pitzer VE, Patalon T. Short term, relative effectiveness of four doses versus three doses of BNT162b2 vaccine in people aged 60 years and older in Israel: retrospective, test negative, case-control study. Bmj. 2022;377:e071113. [accessed 2022 May 25]. doi:10.1136/bmj-2022-071113.
   PubMedGoogle Scholar
• Mallapaty S. Fourth dose of COVID vaccine offers only slight boost against Omicron infection. Nature. 2022. [accessed 2022 Feb 25]. doi:10.1038/d41586-022-00486-9.
   Google Scholar